AstraZeneca Stock Jumps As Upbeat Guidance Offsets Mixed Quarterly ReportInvestors Business Daily • 02/09/23
As demand for Covid vaccines falls, AstraZeneca lines up 'blockbuster' products for 2023CNBC • 02/09/23
AstraZeneca PLC modestly undershoots consensus in the fourth quarter; targeting low double digit sales growth this yearProactive Investors • 02/09/23
Top 5 Health Care Stocks That May Rally - AstraZeneca (NASDAQ:AZN), Amgen (NASDAQ:AMGN)Benzinga • 02/03/23
TEZSPIRE® approved for self-administration in the US with a new pre-filled penBusiness Wire • 02/02/23
TROPION-Lung07 Phase 3 Trial Initiated to Evaluate Datopotamab Deruxtecan in Combination with Pembrolizumab in Patients with Previously Untreated Metastatic Non-Small Cell Lung CancerBusiness Wire • 01/30/23
FDA withdraws Covid antibody treatment Evusheld because it's not effective against 93% of subvariantsCNBC • 01/27/23
AstraZeneca's preventive COVID therapy no longer effective against current variantsMarket Watch • 01/26/23
ENHERTU® Approved in the EU as the First HER2 Directed Therapy for Patients with HER2 Low Metastatic Breast CancerBusiness Wire • 01/26/23
Thermo Fisher Scientific Partners with AstraZeneca to Develop Solid Tissue and Blood-Based Companion Diagnostic Test for TagrissoBusiness Wire • 01/24/23
AIM ImmunoTech shares rise on news of pancreatic cancer research partnership with AstraZeneca and Erasmus Medical CenterProactive Investors • 01/17/23